Mineralys Therapeutics logo

Mineralys Therapeutics

Brand

5.0

Company overview

At Mineralys Therapeutics we aim to redefine hypertension diagnosis, management and treatment. We are driven to break the “trial and failure” approach to hypertension management and bring a personalized approach to the management of hypertension.
Founded in 2020
Wayne, Pennsylvania, USA
84 employees (3 in marketing)
www.mineralystx.com
0% recommend to a friend
0% positive business outlook

Salaries

Typical salary range

$175,000 – $250,000

/ yr

Help build salary transparency at Mineralys Therapeutics

Share your compensation anonymously to see full data.

Contribute

People

Hiring activity

Open marketing jobs over time

9 open now

Headcount trend

Company growth over the last 12 months

Headcount +29.2% year over year

Funding

Total funding

$740.5M

Last raise

$287.5M

Post IPO Equity, 7 months ago

Funding history

Sep 2025

Post IPO Equity Mineralys Therapeutics · $287.5M

Mar 2025

Post IPO Equity Mineralys Therapeutics · $175M

Feb 2024

Post IPO Equity Mineralys Therapeutics · $120M

Jun 2022

Series B Mineralys Therapeutics · $118M

Jan 2022

Series A Mineralys Therapeutics

Apr 2021

Series A Mineralys Therapeutics · $40M

Audience

Monthly website visitors
9.8K
Month over month+30%
Quarter over quarter-4.2%
Top sourceDirect (44.3%)
Ad budget per month$0.0
Average search rank44.9
Traffic source mix
Direct
44.3%
Search
35.6%
Social
12.7%
Referral
5.7%
Paid referral
1.5%

LinkedIn followers

Follower count and growth

Total followers

11.1K

12-mo growth

+42.9%

Monthly growth

+9.5%

News

Links

www.mineralystx.comLinkedInCrunchbaseX (Twitter)
Glassdoor